Synthesis, storage and regulated secretion of tissue-type plasminogen activator by cultured rat heart endothelial cells

Fibrinolysis and Proteolysis

Volumn 12, Issue 1, 1998, Pages 9-16

  Emeis, J J ^a   Van Den Hoogen, C M ^a   Diglio, C A ^b  

^a TNO   (Netherlands)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO CYCLIC AMP; CALCIMYCIN; CHOLERA TOXIN; FORSKOLIN; PHORBOL 13 ACETATE 12 MYRISTATE; PLASMINOGEN ACTIVATOR INHIBITOR; RETINOIC ACID; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HEART; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; RAT; VASCULAR ENDOTHELIUM;

EID: 0031921535     PISSN: 13690191     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(98)80003-9     Document Type: Article

References (42)

1. Emeis J J, van den Eijnden-Schrauwen Y, Kooistra T. Tissue-type plasminogen activator and the vessel wall: synthesis, storage and secretion. In: van Hinsbergh VWM, ed. Vascular control of haemostasis. Victoria: Gordon and Breach Science Publishers, 1996; 187-206.
2. Wun T-C, Capuano A. Spontaneous fibrinolysis in whole human plasma. Identification of tissue activator-related protein as the major plasminogen activator causing spontaneous activity in vitro. J Biol Chem 1985; 260: 5061-5066.
3. Van Hinsbergh VWM, Kooistra T, Emeis JJ, Koolwijk P. Regulation of plasminogen activator production by endothelial cells: role in fibrinolysis and local proteolysis. Int J Radiation Biol 1991; 60: 261-272.
4. r = 54,000) from cultured human endothelial cells indistinguishable from urinary urokinase. J Biol Chem 1984; 259: 7198-7205.
5. Van Hinsbergh VWM, Binnema D, Scheffer MA, Sprengers ED, Kooistra T, Rijken DC. Production of plasminogen activators and inhibitor by serially propagated endothelial cells from adult human blood vessels. Arteriosclerosis 1987; 7: 389-400.
6. Grøndahl-Hansen J, Kirkeby LT, Ralfkiaer E, Kristensen P, Lund LR, Danø K. Urokinase-type plasminogen activator in endothelial cells during acute inflammation of the appendix. Am J Pathol 1989; 135: 631-636.
7. Grøndahl-Hansen J, Ralfkiaer E, Kirkeby LT, Kristensen P, Lund LR, Danø K. Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans. Am J Pathol 1991; 138: 111-117
8. Bukovsky A, Labarrere CA, Carter C, Haag B, Faulk WP. Novel immunohistochemical markers of human renal allograft dysfunction - antithrombin III, Thy-1, urokinase, and alpha-smooth muscle actin. Transplantation 1992; 54: 1064-1071.
9. Bacharach E, Itin A, Keshet E. In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. Proc Natl Acad Sci (USA) 1992; 89: 10686-10690.
10. Schneiderman J, Sawdey MS, Keeton M, Bordin GM, Bernstein EF, Dilley RB, Loskutoff DJ. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci (USA) 1992; 89: 6998-7002.
11. Keeton M, Eguchi Y, Sawdey M, Ahn C, Loskutoff DJ. Cellular localization of type 1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissue. Am J Pathol 1993; 142: 59-70.
12. Lupu F, Bergonzelli GE, Heim DA, Cousin E, Genton CY, Bachmann F, Kruithof EKO. Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries. Arterioscler Thromb 1993; 13: 1090-1100.
13. Whawell SA, Wang Y, Fleming K A, Thompson EM, Thompson JN. Localization of plasminogen activator inhibitor-1 production in inflamed appendix by in situ mRNA hybridization. J Pathol 1993; 69: 67-71.
14. Fearns C, Samad F, Loskutoff DJ. Synthesis and localization of PAI-1 in the vessel wall. In: van Hinsbergh VWM, ed. Vascular control of haemostasis. Victoria: Gordon and Breach Science Publishers, 1996; 207-226.
15. Diglio CA, Grammas P, Giacomelli F, Wiener J. Rat heart-derived endothelial and smooth muscle cell cultures: isolation, cloning and characterization. Tissue & Cell 1988; 20: 477-492.
16. Voyta JC, Via DP, Butterfield CE, Zetter BR. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J Cell Biol 1984; 99: 2034-2040.
17. Verheijen JA, Mullaart E, Chang GTG, Kluft C, Wijngaards G. A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemost 1982; 48: 266-269.
18. Padró T, Quax PHA, van den Hoogen CM, Roholl P, Verheijen J, Emeis JJ. Tissue-type plasminogen activator and its inhibitor in rat aorta. Effect of endotoxin. Arterioscler Thromb 1994; 14: 1459-1465.
19. Emeis JJ, Hoekzema R, de Vos AR Inhibiting interleukin-1 and tumour necrosis factor-α does not reduce the induction of plasminogen activator inhibitor type-1 by endotoxin in rats in vivo. Blood 1995; 85: 115-120.
20. Lijnen HR, Webb PD, van Hoef B, de Cock F, Stassen JM, Prior SD, Collen D. Biochemical and biological properties of a recombinant tissue-type plasminogen activator derived from the rat JMI-229 cell line. Thromb Haemost 1992; 67: 239-247.
21. Verheijen JH, Chang GTG, Kluft C. Evidence for the occurrence of a fast-acting inhibitor for plasminogen activator in human plasma. Thromb Haemost 1984; 51: 392-395.
22. Tranquille N, Emeis JJ. The simultaneous acute release of tissue-type plasminogen activator and von Willebrand factor in the perfused rat hindleg region. Thromb Haemost 1990; 63: 454-458.
23. Granelli-Piperno A, Reich E. A study of proteases and proteaseinhibitor complexes in biological fluids. J Exp Med 1978; 148: 223-234.
24. Feng P, Ohlsson M, Ny T. The structure of the TATA-less rat tissue plasminogen activator gene. J Biol Chem 1990; 265: 2022-2027.
25. Enomoto K, Gill DM. Molecular mechanism of the activation of adenylate cyclase by cholera toxin. In: Burgen ASV, Roberts GCK, eds. Topics in Molecular Pharmacology. Amsterdam: Elsevier Science Publishers, 1983; 151-180.
26. Seamon KB, Daly JW. Forskolin, cAMP and cellular physiology. Trends Pharmacol Sci 4: 120, 1983
27. van den Eijnden-Schrauwen Y, Kooistra T, de Vries REM, Emeis JJ. Studies on the acute release of tissue-type plasminogen activator from human endothelial cells in vitro and in rats in vivo: evidence for a dynamic storage pool. Blood 1995; 85: 3510-3517.
28. Kooistra T, Opdenberg JP, Toet K, Hendriks HFJ, van den Hoogen CM, Emeis JJ. Stimulation of tissue-type plasminogen activator synthesis by retinoids in cultured human endothelial cells and rat tissues in vivo. Thromb Haemost 1991; 65: 565-572.
29. Van Bennekum AM, Emeis JJ, Kooistra T, Hendriks HFJ. Modulation of tissue-type plasminogen activator by retinoids in rat plasma and tissues. Am J Physiol 1993; 264: R931-R937.
30. Padró T, van den Hoogen CM, Emeis JJ. Distribution of tissue-type plasminogen activator (activity and antigen) in rat tissues. Blood Coag Fibrinol 1990; 1: 601-608.
31. Smokovitis A. Regions of constantly increased plasminogen activator activity along the intima of the normal aorta. Haemostasis 1978; 7: 303-319.
32. Kooistra T, Emeis JJ. Agents which increase synthesis and release of tissue-type plasminogen activator. In: Bachmann F, ed. Handbook of Experimental Pharmacology. Springer Verlag, New York (in press).
33. Tranquille N, Emeis JJ. Protein synthesis inhibition by cycloheximide does not affect the acute release of tissue-type plasminogen activator. Thromb Haemost 1989; 61: 442-447.
34. Emeis JJ, van den Eijnden-Schrauwen Y, van den Hoogen CM, de Priester W, Westmuckett A, Lupu F. An endothelial storage granule for tissue-type plasminogen activator. J Cell Biol 1997; 139: 245-256.
35. Smith D, Gilbert M, Owen WG. Tissue plasminogen activator release in vivo in response to vasoactive agents. Blood 1985; 66: 835-839.
36. Emeis JJ, Kluft C. PAF-acether-induced release of tissue-type plasminogen activator from vessel walls. Blood 1985; 66: 86-91.
37. Emeis JJ, Tranquille N. On the role of bradykinin in secretion from vascular endothelial cells. Agents Actions 1992; 38: suppl 11: 285-291.
38. Smalley DM, Fitzgerald JE, O'Rourke J. Adenosine diphosphate stimulates the endothelial release of tissue-type plasminogen activator but not von Willebrand factor from isolated-perfused rat hind limbs. Thromb Haemost 1993; 70: 1043-1046.
39. Klöcking H-P. Pharmakologische Beeinflussung der Freisetzung von t-PA aus dem Gefässendothel. Hämostaseologie 1991; 11: 76-88.
40. Emeis JJ. Normal and abnormal endothelial release of tissuetype plasminogen activator. In: Glas-Greenwalt P, ed. Fibrinolysis in disease. Boca Raton: CRC Press, 1996; pp 55-64.
41. Theuring F, Kooistra T, Schleuning W-D. Pharmacological modulation of gene expression in t-PA-lacZ transgenic mice. In: Klug S, Thiel R, eds. Methods in Developmental Toxicology and Biology. Berlin: Blackwell, 1997; in press.
42. Derhaag JG, Duijvestijn AM, Emeis JJ, Engels W, van Breda Vriesman PJC. Production and characterization of spontaneous rat heart endothelial cell lines. Lab Invest 1996; 74: 437-451.